Skip to main content
Clinical Trials/CTRI/2024/02/063057
CTRI/2024/02/063057
Not yet recruiting
Phase 4

A comparative study of efficacy and safety ofintralesional acyclovir 70mg/ml vs 100mg/ml in common warts including palmoplantar and periungual warts - nil

Dr RPGMC Kangra at Tanda0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Sponsor
Dr RPGMC Kangra at Tanda
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr RPGMC Kangra at Tanda

Eligibility Criteria

Inclusion Criteria

  • Warts \<10 in number

Exclusion Criteria

  • Pregnant and lactating women
  • Children \<12 years
  • Hypersensitivity to acyclovir
  • Patients with multiple warts ( \>10\)
  • Patients who received any other treatment for warts at least 1 month before the study
  • Patients on antiviral medication for other indications
  • Not willing to participate or give consent

Outcomes

Primary Outcomes

Not specified

Similar Trials